150 related articles for article (PubMed ID: 4563138)
1. Detection of endotoxin in commercial L-asparaginase preparations by complement fixation and separation by chromatography.
Loos M; Vadlamudi S; Meltzer M; Shifrin S; Borsos T; Goldin A
Cancer Res; 1972 Nov; 32(11):2292-6. PubMed ID: 4563138
[No Abstract] [Full Text] [Related]
2. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
Charles LM; Bono VH
Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
[No Abstract] [Full Text] [Related]
3. Effect of in vivo treatment with L-asparaginase on the in vitro uptake and phosphorylation of some antileukemic agents.
Nahas A; Capizzi RL
Cancer Res; 1974 Oct; 34(10):2689-93. PubMed ID: 4413062
[No Abstract] [Full Text] [Related]
4. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
Vadlamudi S; Krishna B; Reddy VV; Goldin A
Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
[No Abstract] [Full Text] [Related]
5. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
Capizzi RL; Summers WP; Bertino JR
Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
[No Abstract] [Full Text] [Related]
6. Chemical modification of L-asparaginase with comb-shaped copolymer of poly(ethylene glycol) derivative and maleic anhydride.
Saito T; Ueno T; Sekine T; Kodera Y; Hiroto M; Matsushima A; Nishimura H; Inada Y
Leukemia; 1997 Apr; 11 Suppl 3():408-9. PubMed ID: 9209407
[TBL] [Abstract][Full Text] [Related]
7. L-asparaginase--antileukemia agent.
Bukhari SZ; Yaqub M
J Pak Med Assoc; 1977 Jan; 27(1):262-4. PubMed ID: 19639
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressants.
Ashworth LA; MacLennan AP
Cancer Res; 1974 Jun; 34(6):1353-9. PubMed ID: 4596965
[No Abstract] [Full Text] [Related]
9. Effect of endotoxin on the serum level of complement components. II. Effect of endotoxin on dog serum complement level in vivo and in vitro.
Füst G; Keresztes M
Acta Microbiol Acad Sci Hung; 1969; 16(2):135-47. PubMed ID: 4907582
[No Abstract] [Full Text] [Related]
10. Activation of the classic and alternate complement pathways by endotoxin.
Fine DP
J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
[No Abstract] [Full Text] [Related]
11. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
Broome JD
Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
[No Abstract] [Full Text] [Related]
12. The immunodepressive activity of Escherichia coli L-asparaginase in some transplantation systems.
Brambilla G; Parodi S; Cavanna M; Caraceni CE; Baldini L
Cancer Res; 1970 Nov; 30(11):2665-70. PubMed ID: 4395089
[No Abstract] [Full Text] [Related]
13. [L-asparaginase--first specific cytostatic].
Marquardt H
Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
[No Abstract] [Full Text] [Related]
14. [Action of a guinea pig serum asparaginase preparation on normal and leukemic mouse lymphocytes].
Kastrikin NF
Patol Fiziol Eksp Ter; 1972; 16(5):79-80. PubMed ID: 4670459
[No Abstract] [Full Text] [Related]
15. [Electron microscopic observations on the effect of L-asparaginase at transplanted leukemias of the mouse].
Voigt WH; Grundmann E; Bierling R
Beitr Pathol Anat; 1970; 140(2):237-55. PubMed ID: 5418958
[No Abstract] [Full Text] [Related]
16. Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase.
Boyse EA; Old LJ; Campbell HA; Mashburn LT
J Exp Med; 1967 Jan; 125(1):17-31. PubMed ID: 5334543
[TBL] [Abstract][Full Text] [Related]
17. Influence of a benign virus upon mouse leukemia during asparaginase therapy.
Riley V
Pathol Biol (Paris); 1970; 18(15):757-64. PubMed ID: 4917552
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
Avery TL; Roberts D
Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
[No Abstract] [Full Text] [Related]
19. [Antineoplastic effect of L-asparaginase].
Opolski A
Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
[No Abstract] [Full Text] [Related]
20. Activation of the complement system by interferon inducers.
Rathová V; Kocisková D; Borecký L
Acta Virol; 1972 Nov; 16(6):508. PubMed ID: 4404904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
